Vicarious Surgical Inc (NYSE:RBOT) CTO Sells $10,955.62 in Stock

Vicarious Surgical Inc (NYSE:RBOT) CTO Sammy Khalifa sold 754 shares of the stock in a transaction dated Thursday, February 20th. The stock was sold at an average price of $14.53, for a total transaction of $10,955.62. Following the transaction, the chief technology officer now directly owns 36,927 shares in the company, valued at $536,549.31. This trade represents a 2.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Sammy Khalifa also recently made the following trade(s):

• On Monday, December 23rd, Sammy Khalifa sold 112 shares of Vicarious Surgical stock. The stock was sold at an average price of $12.19, for a total value of $1,365.28.
• On Tuesday, December 3rd, Sammy Khalifa sold 239 shares of Vicarious Surgical stock. The shares were sold at an average price of $13.46, for a total value of $3,216.94.

Vicarious Surgical Trading Down 1.6 %

Shares of RBOT opened at $14.38 on Monday. The stock has a 50 day moving average of $13.65 and a 200 day moving average of $10.14. The company has a market capitalization of $84.99 million, a price-to-earnings ratio of -1.40 and a beta of 1.32. Vicarious Surgical Inc has a 12 month low of $4.27 and a 12 month high of $19.00.

Institutional Investors Weigh In On Vicarious Surgical

Large investors have recently made changes to their positions in the business. Geode Capital Management LLC boosted its holdings in shares of Vicarious Surgical by 8.2% in the 4th quarter. Geode Capital Management LLC now owns 30,799 shares of the company’s stock worth $405,000 after buying an additional 2,336 shares during the last quarter. DnB Asset Management AS raised its position in Vicarious Surgical by 21.1% in the fourth quarter. DnB Asset Management AS now owns 21,213 shares of the company’s stock worth $279,000 after acquiring an additional 3,692 shares during the period. Finally, Renaissance Technologies LLC boosted its stake in Vicarious Surgical by 11.6% in the fourth quarter. Renaissance Technologies LLC now owns 11,534 shares of the company’s stock valued at $152,000 after acquiring an additional 1,200 shares during the last quarter. 47.27% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Separately, Piper Sandler cut their target price on Vicarious Surgical from $12.00 to $10.50 and set a “neutral” rating on the stock in a report on Wednesday, November 13th.

Vicarious Surgical Company Profile

Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.